Underground Biohacking
Sleep

DSIP

Chris Hallewell, founder of Underground Biohacking

By , Founder, Underground Biohacking

Last reviewed

Research use only. Not FDA-approved.

DSIP is a small brain peptide named for the deep sleep waves it was thought to trigger. Human trials exist, but they are old, small, and they disagree. Some 1980s studies found better sleep in people with insomnia. Two double-blind trials found gains too small to matter. A 2009 anaesthesia trial found it cut delta waves instead of raising them. No regulator has approved it as a medicine. The evidence is weak and unsettled.

What is DSIP?

DSIP stands for delta sleep-inducing peptide. It is a chain of nine amino acids, the building blocks that make up all proteins. Researchers first found it in the 1970s, in blood taken from rabbits whose brains were being stimulated into sleep. The name came from that experiment: delta waves are the slow brain waves of deep sleep. It is classed as a neuropeptide, a short protein fragment that acts as a signal in the nervous system. Unlike most peptides, DSIP crosses the blood-brain barrier, the filter that keeps most large molecules out of the brain. That is why an injection into a vein can affect brain activity at all. Its size cuts both ways. Nine amino acids is small enough to slip past that barrier, but also small enough to be broken down fast. Every human trial gave it by injection into a vein. Researchers still have not agreed on how it works in the body. That gap is part of why it never became a licensed medicine.

What is DSIP used for?

  • In 14 people with severe chronic insomnia, a week of DSIP injections improved night sleep.[1]Human study
  • In six healthy volunteers, a morning infusion increased median total sleep time by 59 percent over the next two hours.[2]Human study
  • In six middle-aged people with chronic insomnia, the authors concluded DSIP had a normalising influence on sleep regulation.[3]Human study
  • In a double-blind crossover trial in people with insomnia, the sleep gains were judged of little clinical significance.[4]Human study
  • In 16 people with chronic insomnia, short-term DSIP was judged unlikely to be of major therapeutic benefit.[5]Human study
  • In a pilot study of seven people with chronic pain, pain levels fell significantly in six of them.[6]Human study
  • In 11 healthy men, a single injection lowered ACTH, the pituitary hormone that drives cortisol release.[7]Human study
DSIP dosage chart
Typical dose100-300mcg per dose, 30 minutes before sleep
Cycle length4-8 weeks; pulsed use also common
FormInjectable (subcutaneous), intranasal

How many units is your DSIP dose?

Enter your vial, water and dose. Get the units to draw.

Open the DSIP calculator →

How does DSIP work?

Delta-sleep-inducing peptide. A nonapeptide that crosses the blood-brain barrier. Modulates HPA-axis activity and increases delta-wave (slow-wave) sleep architecture. Also studied for stress resilience and chronic pain.

How much DSIP should you take?

100-300mcg per dose, 30 minutes before sleep

How long should you run DSIP?

4-8 weeks; pulsed use also common

How is DSIP supplied?

Injectable (subcutaneous), intranasal

What are the side effects of DSIP?

EffectHow seriousWhat to watch
Faster heart rate and reduced heart rate variability during anaesthesia.[8]Measurable, seen in one small trialHeart rate, and any palpitations.
Anaesthesia became lighter rather than deeper, which points to a drop in calming (parasympathetic) nerve tone.[8]Unclear, and the opposite of the expected effectTell an anaesthetist before any surgery.
Researchers noted that the amounts used in human studies were already known to change ECG (heart tracing) patterns.[9]UnknownAny chest symptoms or palpitations, and raise them with a doctor.
In an early short study in healthy people, no side effects of any kind were recorded.[2]None reportedNone
There is no long-term human safety record. Every trial was short, and no modern safety study has been run.UnknownNone that is meaningful, because nobody knows what to watch for.

Is DSIP legal in 2026?

Checked on 6 August 2026. The FDA lists emideltide, its name for DSIP, on its page of bulk drug substances that may present significant safety risks. DSIP sits in the group whose nomination was withdrawn by the people who nominated it. The FDA writes that it has not identified safety information for the proposed route, so it cannot know whether the drug would harm people. It also flags a risk of immunogenicity (your immune system reacting to the drug) and problems with impurities. An FDA advisory committee met on 23 to 24 July 2026. DSIP was the one substance the panel voted against. The count was 6 in favour, 7 against, with 1 abstention. That vote is advice only. It is not binding, and it changes nothing about the legal position.

Status checked against the primary source.

Where to buy DSIP

Running DSIP in your next protocol cycle?

Check out our recommended sources list to find vetted vendors you can trust.

View sources

DSIP protocols

Deep dives on DSIP

Frequently Asked Questions

Does DSIP actually help you sleep?
Maybe, a little, but the evidence is thin. Small 1980s trials in people with insomnia reported longer sleep and fewer wakings. Two later double-blind trials found the same direction of change, but far too small to matter in real life. One team concluded short-term use was unlikely to help much. No large modern trial has ever been run. So the honest answer is that nobody has properly settled it.
Why do the old studies disagree with each other?
Mostly because they were tiny. Most enrolled fewer than twenty people. At that size, one good sleeper or one bad night can swing the result. The early positive studies often came from the same research group that discovered the peptide. Later independent teams found weaker effects. Sleep is also easy to measure badly, and people report their own sleep unreliably. Small studies plus a subjective outcome is a recipe for mixed findings.
Is DSIP legal to buy or to be prescribed?
No approved DSIP medicine exists in the United States. The FDA has placed emideltide, its name for DSIP, among bulk substances that may present significant safety risks. The nomination to allow it in compounded medicines was withdrawn. An advisory committee voted against it in July 2026, and that vote was advice, not law. Nothing about its status has changed or been restored. Anything sold online is unapproved, and its purity is nobody's guarantee.
Is DSIP safe?
Nobody knows. The old trials were short and reported few problems. One 1981 study said it was well tolerated with no side effects seen. But a 2009 anaesthesia trial found it raised heart rate and reduced heart rate variability. Another group noted that the amounts used in studies were known to alter ECG traces. The FDA says it lacks the safety information needed to judge whether it would harm people. There is no long-term human safety record at all.
What did the 2009 anaesthesia trial find?
That trial is the most surprising piece of the story. Researchers gave DSIP to women having surgery under isoflurane anaesthesia. They expected it to deepen sleep and raise delta brain waves. It did the opposite. Delta rhythm fell, the anaesthesia got lighter on the monitor, and heart rate rose. The authors thought DSIP had reduced parasympathetic nerve tone, the calming side of the nervous system. That result sits badly with the peptide's own name.
Should I try DSIP for my insomnia?
That is a decision for you and a doctor, not a website. What the evidence supports is modest at best, and half the trials found nothing useful. There is no approved product, so anything you find is unregulated. Insomnia has treatments with far stronger evidence behind them, including cognitive behavioural therapy for insomnia. If you still want to discuss DSIP, ask your doctor what is actually known about its safety.

References

  1. 1.Schneider-Helmert D (1987). Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia. European neurology. PMID: 3622582. DOI: 10.1159/000116143.
  2. 2.Schneider-Helmert D, et al. (1981). Acute and delayed effects of DSIP (delta sleep-inducing peptide) on human sleep behavior. International journal of clinical pharmacology, therapy, and toxicology. PMID: 6895513.
  3. 3.Schneider-Helmert D, Schoenenberger GA (1981). The influence of synthetic DSIP (delta-sleep-inducing-peptide) on disturbed human sleep. Experientia. PMID: 7028502. DOI: 10.1007/BF01971753.
  4. 4.Monti JM, et al. (1987). Study of delta sleep-inducing peptide efficacy in improving sleep on short-term administration to chronic insomniacs. International journal of clinical pharmacology research. PMID: 3583493.
  5. 5.Bes F, et al. (1992). Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study. Neuropsychobiology. PMID: 1299794. DOI: 10.1159/000118919.
  6. 6.Larbig W, et al. (1984). Therapeutic effects of delta-sleep-inducing peptide (DSIP) in patients with chronic, pronounced pain episodes. A clinical pilot study. European neurology. PMID: 6548970. DOI: 10.1159/000115716.
  7. 7.Bjartell A, et al. (1989). Reduction of immunoreactive ACTH in plasma following intravenous injection of delta sleep-inducing peptide in man. Psychoneuroendocrinology. PMID: 2554357. DOI: 10.1016/0306-4530(89)90004-8.
  8. 8.Pomfrett CJ, et al. (2009). Delta sleep-inducing peptide alters bispectral index, the electroencephalogram and heart rate variability when used as an adjunct to isoflurane anaesthesia. European journal of anaesthesiology. PMID: 19142086. DOI: 10.1097/EJA.0b013e32831c8644.
  9. 9.Giusti M, et al. (1993). Delta sleep-inducing peptide administration does not influence growth hormone and prolactin secretion in normal women. Psychoneuroendocrinology. PMID: 8475226. DOI: 10.1016/0306-4530(93)90057-r.

This content is for educational purposes only. These compounds are intended for research use. Nothing here is medical advice.